Stock Comparison

NRXP vs UNH

NRX Pharmaceuticals Inc vs UnitedHealth Group Inc

The Verdict

NRXP takes this one.

Winner

NRXP

NRX Pharmaceuticals Inc

3.0

out of 10

Risk Trap

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Head-to-Head

N/A

Market Cap

$276.2B

N/A

P/E Ratio

22.9

N/A

Profit Margin

2.7%

N/A

Return on Equity

12.5%

N/A

Debt-to-Equity

0.0

Aggressive

Overall Risk

Moderate-High

3.0

DVR Score

0.3

The Deep Dive

NRXP3.0/10

NRXP continues to possess a high-impact asset in NRX-101 for Bipolar Depression with Suicidal Ideation, bolstered by Breakthrough Therapy designation and targeting a significant unmet medical need. This offers substantial market potential for future leadership within its niche. However, the company's financial state remains critically precarious, characterized by chronic low cash reserves, a high ...

Full NRXP Analysis

UNH0.3/10

UnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.